Journal
CANCER
Volume 115, Issue 2, Pages 381-389Publisher
WILEY
DOI: 10.1002/cncr.24041
Keywords
cerebrospinal fluid; leptomeningeal carcinomatosis; meningeal carcinomatosis; prognostic factors
Categories
Funding
- Ministerio de Sanidad y Consumo of Spain [FIS 05/0689, FIS 07/0493, FIS 08/1085, ISCIII-RETICC RD06/0020]
Ask authors/readers for more resources
BACKGROUND: Leptomeningeal carcinomatosis (LC) represents a devastating complication of systemic cancer, and patients with LC have a dismal prognosis and increased mortality. The few studies that have focused on the evaluation of prognostic factors in patients with LC have resulted in contradictory results. Thus, the treatment of LC remains controversial, and no straightforward guidelines exist in the literature. The objective of the current study was to identify prognostic markers related to LC survival to better select patients who are eligible for intensive treatment. METHODS: Seventy patients who had a diagnosis of LC were reviewed, and clinical data, cerebrospinal fluid (CSF) parameters, tumor-related characteristics, and treatment information were registered. The impact of single parameters on overall survival was determined by both univariate and multivariate analyses. RESULTS: The multivariate analysis revealed that Radiation Therapy Oncology Group score <2 (P = .028), a glucose level in CSF >= 2.7 mmol/L (P = .001), the presence of infratentorial symptoms at onset (P = 026), and intrathecal treatment (P < .001) were associated independently with longer overall survival in patients with LC. In addition, the same clinical factors also predicted response to treatment in such patients. CONCLUSIONS: The predictive factors for patients with LC that were identified in this study could help to better select patients who are more likely to benefit from chemotherapy. Cancer 2009;115:381-9. (C) 2009 American Cancer Society.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available